Close Menu

Clear Labs Clear Safety NGS Platform

Feb 19, 2019

Clear Labs has released a software update for its Clear Safety NGS platform, which now includes Salmonella serotyping. According to the firm, food safety professionals can now detect up to 40 unique Salmonella serotypes in an enriched sample in about 24 hours. With the update, Clear Labs said that the platform allows food manufacturers and service labs to test for the presence or absence of pathogens and serotypes at the same time. In addition, the firm noted that customers can now choose if they want to test for the disease at the genus level, species level, or the serotype level. 

More Like This

Jan 23, 2020

IDT: xGen Exome Research Panel v2

Integrated DNA Technologies has launched the xGen Exome Research Panel v2.

The next-generation sequencing panel offers improved on-target rates and uniformityincreased sample coverage, updated content, and enhanced performance. The retail price is $8 per sample, which IDT said is a reduction of more than 50 percent, compared to the previous version. 

Each of the panel's 415,115 probes are individually synthesized on IDT's newest platform, Gemini, and manufactured for one large synthesis lot to ensure reproducible results and avoid lot-to-lot revalidations. 

Potential applications for the assays include population studies, rare disease research, and oncology. 

Jan 23, 2020

Meridian Bioscience High Specificity Pfu HS Mix

Meridian Bioscience launched a High-Specificity Pfu Hs Mix to provide high-fidelity amplification and amplification for companion diagnostic and clinical testing. The solution cuts down on the possibility of uneven amplification of diverse types of sequences. Meridian said the mix has "market-leading properties in terms of" inhibitor resistance, multiplexing, and low GC bias and can be used in next-generation sequencing and PCR applications. 

Jan 21, 2020

OptraHealth GeneFax Pro

OptraHealth has introduced a version of GeneFax Pro on the Microsoft Azure Marketplace. GeneFax Pro is a conversational chatbot program featuring natural-language processing and artificial intelligence to educate patients about genetic testing, gauge interest in specific tests, and automate pre-test counseling and patient consent. 

Jan 17, 2020

MGI Tech: DNBSEQ-G400 FAST

MGI Tech has launched the DNBSEQ-G400 FAST next-generation sequencer in China and Japan. The G400 is also known as MGISEQ-2000 in China and some other markets.

The G400 FAST is a mid-throughput instrument offering maximum output of 330 gigabases for applications including targeted NGS, single-cell sequencing, and whole-genome and -exome sequencing.

The instrument offers two lanes with 550 million effective reads per flow cell. The average run time is between 12 and 37 hours.  Maximum read length is PE150.

Jan 17, 2020

MGI One Million Genomes Total Solution

MGI has released One Million Genomes Total Solution, a software and hardware solution for large-scale population genome sequencing projects that combines sample preparation, high-throughput sequencing, and data analysis. The package consists of a whole-blood pretreatment system that has an annual output of up to 600,000 samples, an automated library preparation system with an annual output of up to 500,000 samples, and MGI's ultra-high-throughput DNBSEQ-T7 sequencer that can sequence 600,000 to 800,000 samples per year. It also includes a data processing platform with computing and storage capabilities that can analyze 100,000 to 1 million samples per year. In addition, the solution integrates a laboratory management system. It uses blockchain technology for data security and privacy.

Jan 17, 2020

Oxford Nanopore Technologies R10.3 Nanopore Chemistry

Oxford Nanopore Technologies has released flow cells using the R10.3 nanopore chemistry. It is currently available for MinIon and PromethIon sequencers and will be available for Flongle flow cells at a later time. The R10.3 chemistry, which is suitable for use with the LSK109 kit at launch, improves on the R10. Like the R10, it uses a pore with a longer barrel and a dual reader head, which improves resolution of homopolymers and consensus accuracy. Compared to the R10, it has increased throughput and capture, is compatible with PromethIon flow cells, has input amounts closer to the R9.4.1 chemistry, and has improved raw accuracy to match the R9.4.1 and to support enhanced variant calling.

Jan 14, 2020

Congenica Neuro

Congenica has introduced Congenica Neuro, a module for the company's clinical decision support platform to help physicians characterize epilepsy and neurodevelopmental disorders. The technology automates prioritization of genetic variants and helps accelerate the identification, review, and reporting of de novo variants by comparing test results to curated gene panels and preconfigured filters, the company said. 

Jan 14, 2020

Biocept Target Selector for CSF

Biocept's Target Selector liquid biopsy assays are now available to physicians to evaluate patients' cerebrospinal fluid for the presence of circulating tumor cells and biomarkers for patients with breast or lung cancer suspected of brain or central nervous system metastases. The presences of such cells may indicate brain metastases. Biocept said that up to 30 percent of patients with breast cancer and up to 36 percent of patients with lung cancer will develop brain metastases.  

Jan 14, 2020

Oxford Gene Technology: SureSeq CLL + CNV Panel

Oxford Gene Technology has launched the SureSeq CLL + CNV Panel for cancer research. The next-generation sequencing assay has been designed in collaboration with cancer experts to detect 12 key genes and five chromosomal regions implicated in chronic lymphocytic leukemia (CLL) progression.

The panel alleviates the burden of running multiple assays and delivers a comprehensive genomic profile for each CLL sample using a single workflow. It can identify loss of heterozygosity, copy number variation with a size range of a single exon to the whole gene, loss of chromosomal arms, and whole chromosome gains in trisomy 12. It comes with complimentary data analysis software.

Jan 14, 2020

Genome Diagnostics NGSengine

Genome Diagnostics has released a new version of its NGSengine human leukocyte antigen typing software. The updated NGSengine is now capable of exporting HLA typing results of individual samples directly to the Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) matching-services website, thanks to a recent partnership between Netherlands-based GenDx and German firm PIRCHE. This, the company said, will give laboratories the ability to predict indirectly recognizable HLA epitopes for either hematopoietic stem cells or solid organs.

Jan 13, 2020

Bio-Rad Laboratories: SEQuoia

Bio-Rad Laboratories announced the launch of the SEQuoia Complete Stranded RNA Library Prep Kit for RNA-Seq library preparation. The kit uses SEQzyme, an enzyme that couples cDNA synthesis with adapter addition in a continuous synthesis reaction. It is compatible with a broad range of sample inputs and allows capture of the complete transcriptome, including short and long RNAs, in a single library prep. The kit generates cDNA libraries suitable for strand-specific next-generation sequencing on Illumina sequencers in less than four hours. It also includes access to the integrated SeqSense analysis solution to process and quality control sequencing data for all RNA biotypes in the library within a single analysis pipeline.

Jan 13, 2020

OncoCyte DetermaRx

OncoCyte has launched the DetermaRx, test for identifying early-stage lung cancer patients who may benefit from adjuvant chemotherapy after surgical resection. The test was formerly known as the Razor treatment stratification test and was being developed by Razor Genomics, which OncoCyte acquired in September. Regulators in Canada have approved the test for marketing in that country, the Irvine, California-based firm said. In the US, Florida Precision Oncology and the Leonard Cancer Institute at Mission Hospital in Mission Viejo, California have signed up as early access users of the test, OncoCyte said. It said that in a clinical study, high-risk patients identified by the test post-surgery and treated with adjuvant chemotherapy had a "significant" increase in survival rates. 

Jan 13, 2020

Dovetail Genomics: Genome Assembly Services With Omni-C

Dovetail Genomics has launched an expanded menu of genome assembly services, including 3D genome conformation analysis, annotations, and chromosome-scale assemblies.

The services leverage the firm's Omni-C technology, which provides improved scaffolding, SNP detection, and haplotype phasing.

Jan 09, 2020

Qiagen QiaSymphony PowerFecal Pro DNA Kit

Qiagen has launched the QiaSymphony PowerFecal Pro DNA Kit for the isolation of microbial genomic DNA from stool and soil using the QiaSymphony automation platform. The new kit enables automated, time-saving, standardized extraction of inhibitor-free DNA from stool and soil samples for metagenomic analysis, and is designed for 192 samples with continuous loading of 24-sample batches. Qiagen said that its new PowerBead Pro tubes are included in the kit for homogenization. The beads and optimized chemistry enable more efficient lysis of bacteria and fungi.

Jan 09, 2020

Pillar Biosciences Onco/Reveal Solid Tumor Panel

Pillar Biosciences has launched the Pillar Onco/Reveal Solid Tumor Panel, a 47-gene enrichment assay for research use. The panel leverages Pillar's SLIMamp enrichment chemistry, which uses primers that are designed to form stem loops to suppress unwanted amplicons during PCR amplification, enabling multiplexed NGS library preparation in a single tube. The test was licensed from Columbia University and recently received approval from the New York State Department of Health.

An initial analysis suggests the novel coronavirus from Wuhan that is sickening people might come from snakes, a team of virologists writes at the Conversation.

DNA testing confirms captured Chicago coyote same as the one that bit a boy near a nature museum, the Chicago Tribune reports.

An analysis of Tibetan ice cores uncovers more than two dozen previously unknown virus groups, LiveScience reports.

In Nature this week: genomic analysis of four children buried in Cameroon approximately 3,000 and 8,000 years ago, and more.